WebMD Health (WBMD) 8-K Other Events

Exhibit 99.1

Selected Financial Data

The following selected consolidated financial data should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and with the consolidated financial statements and notes thereto, which are included in Exhibits 99.2 and 99.3.

	Years Ended December 31,(1)
	2008		2007(2)			2006(3)(4)		2005		2004
	(In thousands, except per share data)
Consolidated Statement of Operations Data:
Revenue	$	373,542	$	319,493		$	239,434	$	154,560	$	120,287
Cost of operations		135,138		114,000			98,692		63,077		45,123
Sales and marketing		106,080		91,035			73,344		49,026		44,976
General and administrative		56,635		59,326			50,060		27,937		20,461
Depreciation and amortization		27,921		26,785			17,154		10,113		5,094
Interest income		10,452		12,378			5,099		1,790		—
Impairment of auction rate securities		27,406		—			—		—		—
Restructuring		2,910		—			—		—		—
Income from continuing operations before income tax provision (benefit)		27,904		40,725			5,283		6,197		4,633
Income tax provision (benefit)		2,211		(17,644	)		3,571		1,367		970
Income from continuing operations		25,693		58,369			1,712		4,830		3,663
Income from discontinued operations, net of tax		1,009		7,515			824		1,735		1,754
Net income	$	26,702	$	65,884		$	2,536	$	6,565	$	5,417
Basic income per common share:
Income from continuing operations	$	0.45	$	1.02		$	0.03	$	0.10	$	0.08
Income from discontinued operations		0.01		0.13			0.02		0.03		0.03
Net income	$	0.46	$	1.15		$	0.05	$	0.13	$	0.11
Diluted income per common share:
Income from continuing operations	$	0.44	$	0.98		$	0.03	$	0.10	$	0.08
Income from discontinued operations		0.01		0.12			0.01		0.03		0.03
Net income	$	0.45	$	1.10		$	0.04	$	0.13	$	0.11
Weighted-average shares outstanding used in computing net income per common share:
Basic		57,717		57,184			56,145		50,132		48,100
Diluted		58,925		59,743			58,075		50,532		48,100

1

	As of December 31,(1)
	2008		2007(2)		2006(3)		2005		2004
	(In thousands)
Consolidated Balance Sheet Data:
Cash and cash equivalents and investments	$	325,222	$	294,653	$	54,150	$	153,777	$	3,456
Working capital (excluding assets and liabilities of discontinued operations)		186,571		290,614		184,966		152,337		9,011
Total assets		755,932		720,173		619,965		376,889		146,496
Other long-term liabilities		8,334		9,210		7,912		7,010		—
Stockholders’ equity		633,718		606,755		496,109		295,955		98,560

(1)	In March 2009, our Board of Directors decided to divest the Little Blue Book print directory business. Accordingly, this selected consolidated financial data has been reclassified to reflect the historical results of the Little Blue Book print directory business as discontinued operations for all periods presented.
(2)	As of December 31, 2007, we completed the sale of our medical reference publications business. Accordingly, this selected consolidated financial data has been reclassified to reflect historical results of our medical reference publications business as discontinued operations for this and all prior periods presented.
(3)	During 2006, we acquired Subimo LLC on December 15, 2006, Medsite Inc. on September 11, 2006, Summex Corporation on June 13, 2006 and eMedicine.com Inc. on January 17, 2006. The results of operations of these acquired companies have been included in our financial statements from the respective acquisition dates.
(4)	On January 1, 2006, we adopted Statement of Financial Accounting Standards No. 123 “(Revised 2004): Share-Based Payment” that resulted in additional non-cash stock-based compensation expense beginning in 2006. See Results of Operations within Management’s Discussion and Analysis of Financial Condition and Results of Operations, which is included in Exhibit 99.2.

2